Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $10.99, but opened at $9.90. Teladoc Health shares last traded at $9.38, with a volume of 6,928,751 shares.
The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.
Analyst Ratings Changes
Several research analysts have recently issued reports on TDOC shares. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a report on Friday, November 1st. TD Cowen decreased their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research note on Thursday. Bank of America lifted their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Finally, Oppenheimer dropped their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and an average target price of $11.44.
Insider Activity at Teladoc Health
In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.95% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Brucke Financial Inc. bought a new stake in Teladoc Health in the 4th quarter valued at $92,000. Vise Technologies Inc. raised its stake in shares of Teladoc Health by 4.9% in the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 1,405 shares during the period. PharVision Advisers LLC bought a new stake in shares of Teladoc Health in the fourth quarter valued at about $301,000. Twinbeech Capital LP boosted its position in shares of Teladoc Health by 63.8% during the fourth quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider’s stock worth $3,479,000 after buying an additional 149,118 shares during the period. Finally, Two Sigma Advisers LP grew its holdings in shares of Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock worth $20,532,000 after buying an additional 1,537,094 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.
Teladoc Health Stock Performance
The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market cap of $1.62 billion, a price-to-earnings ratio of -1.64 and a beta of 1.04. The stock has a 50-day moving average of $10.62 and a 200-day moving average of $9.53.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
- Five stocks we like better than Teladoc Health
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- How to Invest in Blue Chip Stocks
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What is an Earnings Surprise?
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.